176 related articles for article (PubMed ID: 37899522)
1. Cortical Iron Accumulation as an Imaging Marker for Neurodegeneration in Clinical Cognitive Impairment Spectrum: A Quantitative Susceptibility Mapping Study.
Kim HW; Lee S; Yang JH; Moon Y; Lee J; Moon WJ
Korean J Radiol; 2023 Nov; 24(11):1131-1141. PubMed ID: 37899522
[TBL] [Abstract][Full Text] [Related]
2. Associations of quantitative susceptibility mapping with Alzheimer's disease clinical and imaging markers.
Cogswell PM; Wiste HJ; Senjem ML; Gunter JL; Weigand SD; Schwarz CG; Arani A; Therneau TM; Lowe VJ; Knopman DS; Botha H; Graff-Radford J; Jones DT; Kantarci K; Vemuri P; Boeve BF; Mielke MM; Petersen RC; Jack CR
Neuroimage; 2021 Jan; 224():117433. PubMed ID: 33035667
[TBL] [Abstract][Full Text] [Related]
3. Associations of cortical iron accumulation with cognition and cerebral atrophy in Alzheimer's disease.
Yang A; Du L; Gao W; Liu B; Chen Y; Wang Y; Liu X; Lv K; Zhang W; Xia H; Wu K; Ma G
Quant Imaging Med Surg; 2022 Sep; 12(9):4570-4586. PubMed ID: 36060596
[TBL] [Abstract][Full Text] [Related]
4. Increased Iron Deposition on Brain Quantitative Susceptibility Mapping Correlates with Decreased Cognitive Function in Alzheimer's Disease.
Du L; Zhao Z; Cui A; Zhu Y; Zhang L; Liu J; Shi S; Fu C; Han X; Gao W; Song T; Xie L; Wang L; Sun S; Guo R; Ma G
ACS Chem Neurosci; 2018 Jul; 9(7):1849-1857. PubMed ID: 29722955
[TBL] [Abstract][Full Text] [Related]
5. A diagnostic index based on quantitative susceptibility mapping and voxel-based morphometry may improve early diagnosis of Alzheimer's disease.
Sato R; Kudo K; Udo N; Matsushima M; Yabe I; Yamaguchi A; Tha KK; Sasaki M; Harada M; Matsukawa N; Amemiya T; Kawata Y; Bito Y; Ochi H; Shirai T
Eur Radiol; 2022 Jul; 32(7):4479-4488. PubMed ID: 35137303
[TBL] [Abstract][Full Text] [Related]
6. Patterns of Grey Matter Atrophy at Different Stages of Parkinson's and Alzheimer's Diseases and Relation to Cognition.
Kunst J; Marecek R; Klobusiakova P; Balazova Z; Anderkova L; Nemcova-Elfmarkova N; Rektorova I
Brain Topogr; 2019 Jan; 32(1):142-160. PubMed ID: 30206799
[TBL] [Abstract][Full Text] [Related]
7. Imaging characteristic of dual-phase (18)F-florbetapir (AV-45/Amyvid) PET for the concomitant detection of perfusion deficits and beta-amyloid deposition in Alzheimer's disease and mild cognitive impairment.
Lin KJ; Hsiao IT; Hsu JL; Huang CC; Huang KL; Hsieh CJ; Wey SP; Yen TC
Eur J Nucl Med Mol Imaging; 2016 Jul; 43(7):1304-14. PubMed ID: 27003417
[TBL] [Abstract][Full Text] [Related]
8. Patterns of Brain Iron Accumulation in Vascular Dementia and Alzheimer's Dementia Using Quantitative Susceptibility Mapping Imaging.
Moon Y; Han SH; Moon WJ
J Alzheimers Dis; 2016; 51(3):737-45. PubMed ID: 26890777
[TBL] [Abstract][Full Text] [Related]
9. Structural Alteration of Medial Temporal Lobe Subfield in the Amnestic Mild Cognitive Impairment Stage of Alzheimer's Disease.
He P; Qu H; Cai M; Liu W; Gu X; Ma Q
Neural Plast; 2022; 2022():8461235. PubMed ID: 35111220
[TBL] [Abstract][Full Text] [Related]
10. Texture analyses of quantitative susceptibility maps to differentiate Alzheimer's disease from cognitive normal and mild cognitive impairment.
Hwang EJ; Kim HG; Kim D; Rhee HY; Ryu CW; Liu T; Wang Y; Jahng GH
Med Phys; 2016 Aug; 43(8):4718. PubMed ID: 27487889
[TBL] [Abstract][Full Text] [Related]
11. Quantitative Study of the Changes in Cerebral Blood Flow and Iron Deposition During Progression of Alzheimer's Disease.
Li D; Liu Y; Zeng X; Xiong Z; Yao Y; Liang D; Qu H; Xiang H; Yang Z; Nie L; Wu PY; Wang R
J Alzheimers Dis; 2020; 78(1):439-452. PubMed ID: 32986675
[TBL] [Abstract][Full Text] [Related]
12. Evaluation and Prediction of Early Alzheimer's Disease Using a Machine Learning-based Optimized Combination-Feature Set on Gray Matter Volume and Quantitative Susceptibility Mapping.
Kim HG; Park S; Rhee HY; Lee KM; Ryu CW; Lee SY; Kim EJ; Wang Y; Jahng GH
Curr Alzheimer Res; 2020; 17(5):428-437. PubMed ID: 32579502
[TBL] [Abstract][Full Text] [Related]
13. Quantitative Susceptibility Mapping of Brain Iron Relating to Cognitive Impairment in Hypertension.
Qin Z; Wu W; Liu D; Zheng C; Kang J; Zhou H; Meng X; Haacke EM; Wang L
J Magn Reson Imaging; 2022 Aug; 56(2):508-515. PubMed ID: 34989062
[TBL] [Abstract][Full Text] [Related]
14. 18F-FDG Is a Superior Indicator of Cognitive Performance Compared to 18F-Florbetapir in Alzheimer's Disease and Mild Cognitive Impairment Evaluation: A Global Quantitative Analysis.
Khosravi M; Peter J; Wintering NA; Serruya M; Shamchi SP; Werner TJ; Alavi A; Newberg AB
J Alzheimers Dis; 2019; 70(4):1197-1207. PubMed ID: 31322568
[TBL] [Abstract][Full Text] [Related]
15. Predicting conversion from mild cognitive impairment to Alzheimer's disease using brain
Mitolo M; Stanzani-Maserati M; Capellari S; Testa C; Rucci P; Poda R; Oppi F; Gallassi R; Sambati L; Rizzo G; Parchi P; Evangelisti S; Talozzi L; Tonon C; Lodi R; Liguori R
Neuroimage Clin; 2019; 23():101843. PubMed ID: 31071594
[TBL] [Abstract][Full Text] [Related]
16. Quantitative susceptibility mapping to evaluate the early stage of Alzheimer's disease.
Kim HG; Park S; Rhee HY; Lee KM; Ryu CW; Rhee SJ; Lee SY; Wang Y; Jahng GH
Neuroimage Clin; 2017; 16():429-438. PubMed ID: 28879084
[TBL] [Abstract][Full Text] [Related]
17. Voxel-based quantitative susceptibility mapping in Parkinson's disease with mild cognitive impairment.
Uchida Y; Kan H; Sakurai K; Arai N; Kato D; Kawashima S; Ueki Y; Matsukawa N
Mov Disord; 2019 Aug; 34(8):1164-1173. PubMed ID: 31091347
[TBL] [Abstract][Full Text] [Related]
18. The characteristic patterns of individual brain susceptibility networks underlie Alzheimer's disease and white matter hyperintensity-related cognitive impairment.
Chen H; Xu J; Li W; Hu Z; Ke Z; Qin R; Xu Y
Transl Psychiatry; 2024 Apr; 14(1):177. PubMed ID: 38575556
[TBL] [Abstract][Full Text] [Related]
19. Structural magnetic resonance imaging for the early diagnosis of dementia due to Alzheimer's disease in people with mild cognitive impairment.
Lombardi G; Crescioli G; Cavedo E; Lucenteforte E; Casazza G; Bellatorre AG; Lista C; Costantino G; Frisoni G; Virgili G; Filippini G
Cochrane Database Syst Rev; 2020 Mar; 3(3):CD009628. PubMed ID: 32119112
[TBL] [Abstract][Full Text] [Related]
20. ApoE4 effects on automated diagnostic classifiers for mild cognitive impairment and Alzheimer's disease.
Apostolova LG; Hwang KS; Kohannim O; Avila D; Elashoff D; Jack CR; Shaw L; Trojanowski JQ; Weiner MW; Thompson PM;
Neuroimage Clin; 2014; 4():461-72. PubMed ID: 24634832
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
